TipRanks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
LYEL
Lyell Immunopharma
RESEARCH TOOLSreports
Want to see LYEL full AI Analyst Report?

Lyell Immunopharma (LYEL) Ratios

162 Followers

Lyell Immunopharma Ratios

LYEL's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, LYEL's free cash flow was decreased by $ and operating cash flow was $-11.19K. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.36 5.28 7.06 16.07 17.59
Quick Ratio
 5.36 5.28 7.06 16.07 17.59
Cash Ratio
 1.83 1.22 1.96 4.22 3.34
Solvency Ratio
 -3.09 -2.86 -2.99 -2.25 -1.58
Operating Cash Flow Ratio
 -3.34 -3.04 -3.02 -4.74 -4.58
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 136.20M$ 169.09M$ 271.56M$ 459.61M$ 546.99M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.15 0.12 0.08 0.07
Debt-to-Equity Ratio
 0.16 0.21 0.15 0.10 0.08
Debt-to-Capital Ratio
 0.14 0.17 0.13 0.09 0.08
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.33 1.37 1.28 1.15 1.13
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 1.58 2.98 4.51 5.03 5.48
Net Debt to EBITDA
 0.15 0.03 0.23 0.36 0.33
Profitability Margins
Gross Profit Margin
-8537.04%-31952.78%100.00%100.00%100.00%
EBIT Margin
-920285.19%-762355.56%-361104.92%-190006.15%-220.89%
EBITDA Margin
-885037.04%-730302.78%-328922.95%-174429.23%-199.61%
Operating Profit Margin
-711329.63%-566038.89%-588122.95%-190006.15%-220.89%
Pretax Profit Margin
-920285.19%-762355.56%-562285.25%-180486.15%-216.24%
Net Profit Margin
-920285.19%-762355.56%-562285.25%-180486.15%-216.24%
Continuous Operations Profit Margin
-920285.19%-762355.56%-562285.25%-180486.15%-216.24%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
129.38%134.68%95.61%94.99%97.89%
Return on Assets (ROA)
-79.86%-80.71%-69.88%-31.28%-19.53%
Return on Equity (ROE)
-91.62%-110.57%-89.60%-35.82%-21.98%
Return on Capital Employed (ROCE)
-70.80%-70.11%-82.08%-34.52%-20.77%
Return on Invested Capital (ROIC)
-70.80%-67.99%-80.61%-34.22%-20.67%
Return on Tangible Assets
-79.86%-80.71%-69.88%-31.28%-19.53%
Earnings Yield
-108.63%-52.16%-204.96%-48.19%-21.36%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.60 3.99 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 <0.01 <0.01 <0.01 <0.01 0.51
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 0.09
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 <0.01 0.14
Cash Conversion Cycle
 -607.13 -91.51 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 607.13 91.51 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -5.70 -8.78 -12.42 -13.04 -13.72
Free Cash Flow Per Share
 -5.73 -8.82 -12.46 -13.26 -15.69
CapEx Per Share
 0.03 0.05 0.04 0.21 1.97
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.00 1.02 1.14
Dividend Paid and CapEx Coverage Ratio
 -187.43 -192.34 -349.99 -60.94 -6.98
Capital Expenditure Coverage Ratio
 -187.43 -192.34 -349.99 -60.94 -6.98
Operating Cash Flow Coverage Ratio
 -3.61 -2.94 -2.75 -2.59 -2.50
Operating Cash Flow to Sales Ratio
 -4.94K -4.17K -2.66K -1.26K -2.00
Free Cash Flow Yield
-55.85%-28.66%-97.32%-34.17%-22.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.61 -1.92 -9.77 -2.08 -4.68
Price-to-Sales (P/S) Ratio
 8.89K 14.61K 2.74K 3.75K 10.12
Price-to-Book (P/B) Ratio
 0.98 2.12 0.44 0.74 1.03
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.79 -3.49 -1.03 -2.93 -4.42
Price-to-Operating Cash Flow Ratio
 -1.72 -3.51 -1.03 -2.97 -5.06
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 -0.24 -0.08 0.17
Price-to-Fair Value
 0.98 2.12 0.44 0.74 1.03
Enterprise Value Multiple
 -0.85 -1.97 -0.60 -1.78 -4.74
Enterprise Value
 203.85M 516.94M 120.72M 404.43M 801.52M
EV to EBITDA
 -0.85 -1.97 -0.60 -1.78 -4.74
EV to Sales
 7.55K 14.36K 1.98K 3.11K 9.46
EV to Free Cash Flow
 -1.52 -3.43 -0.74 -2.43 -4.14
EV to Operating Cash Flow
 -1.53 -3.45 -0.74 -2.47 -4.73
Tangible Book Value Per Share
 10.01 14.52 29.28 52.19 67.45
Shareholders’ Equity Per Share
 10.01 14.52 29.28 52.19 67.45
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 0.01 6.85
Net Income Per Share
 -10.64 -16.06 -26.23 -18.70 -14.82
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.56 0.95 0.98
Research & Development to Revenue
 5.80K 4.41K 2.81K 1.41K 1.88
SG&A to Revenue
 1.50K 1.25K 853.13 515.25 1.39
Stock-Based Compensation to Revenue
 1.31K 1.16K 543.34 362.18 0.00
Income Quality
 0.54 0.55 0.47 0.70 0.93
Currency in USD